Novavax Stock Climbs Back Into Pattern On Vaccine News

Benzinga2021-12-08

Novavax Inc. shares were trading higher Tuesday after the head of Vaccines Task Force for the European Medicines Agency reportedly said the company's COVID-19 vaccine could soon receive authorization ...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

JANICELSJ
2021-12-08
JANICELSJ
Like please
Skygeemusic
2021-12-08
Skygeemusic
👍
- JANICELSJ:
  Ok
- 732bc2e8:
  [smile]
CherryPang
2021-12-08
CherryPang
Ok
- Gabrielle_20:
  👌
ASMH
2021-12-08
ASMH
Like
tarotsgirl
2021-12-08
tarotsgirl
Any idea which countries using this vaccine?
AliPharma
2021-12-08
AliPharma
ok

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/1104758360?lang=zh_CN&edition=full","thumbnail":"","is_english":true,"pubTime":"2021-12-08 11:51","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1104758360","market":"us","top_or_hot":-1,"title":"Novavax Stock Climbs Back Into Pattern On Vaccine News","media":"Benzinga","content":"<div>\n<p>Novavax Inc. shares were trading higher Tuesday after the head of Vaccines Task Force for the European Medicines Agency reportedly said the company's COVID-19 vaccine could soon receive authorization ...</p>\n\n<a href=\"https://www.benzinga.com/trading-ideas/long-ideas/21/12/24487221/novavax-stock-climbs-back-into-pattern-on-vaccine-news\">网页链接</a>\n\n</div>\n","source":"lsy1606299360108","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Novavax Stock Climbs Back Into Pattern On Vaccine News</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNovavax Stock Climbs Back Into Pattern On Vaccine News\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-08 11:51 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.benzinga.com/trading-ideas/long-ideas/21/12/24487221/novavax-stock-climbs-back-into-pattern-on-vaccine-news><strong>Benzinga</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Novavax Inc. shares were trading higher Tuesday after the head of Vaccines Task Force for the European Medicines Agency reportedly said the company's COVID-19 vaccine could soon receive authorization ...</p>\n\n<a href=\"https://www.benzinga.com/trading-ideas/long-ideas/21/12/24487221/novavax-stock-climbs-back-into-pattern-on-vaccine-news\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"NVAX","symbol_name":"诺瓦瓦克斯医药","start_time":0,"source_url":"https://www.benzinga.com/trading-ideas/long-ideas/21/12/24487221/novavax-stock-climbs-back-into-pattern-on-vaccine-news","article_id":"1104758360","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1104758360","pubTimestamp":1638935491,"sourceInfo":{"source_id":"lsy1606299360108","name":"Benzinga"},"weMediaInfo":null,"summary":"Novavax Inc. shares were trading higher Tuesday after the head of Vaccines Task Force for the Europe","collect":0,"end_time":0,"defaultTopTitle":"benzinga.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"NVAX":"诺瓦瓦克斯医药"},"translate_title":"诺瓦瓦克斯医药股市在疫苗新闻上重回模式","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"NVAX":0.9},"content_text":"Novavax Inc. shares were trading higher Tuesday after the head of Vaccines Task Force for the European Medicines Agency reportedly said the company's COVID-19 vaccine could soon receive authorization in Europe.\nA final decision will take place next week, when it is expected the agency will approve the vaccine.\nNovavax was up 28.89% at $182.85 today.\nNovavax Daily Chart Analysis\n\nShares look to have bounced back higher and are once again trading within what technical traders call a pennant pattern.\nNarrowing highs and lows have condensed this pattern, and it is nearing the point where there is not much room for the stock to go. When this point happens the stock may break out of the pennant pattern and see a strong move in the same direction as the break.\nThe stock crossed above the 50-day moving average (green) Tuesday but trades below the 200-day moving average (blue), indicating sentiment in the stock looks to be turning slightly more bullish.\nThe 50-day moving average may hold as support in the pattern, while the 200-day moving average may act as a resistance level.\nThe Relative Strength Index (RSI) bounced back a bit after falling for the last few weeks and sits at 49. This shows an increase in the amount of buyers in the stock and shows the overall buying pressure almost equals the selling pressure.\n\nWhat’s Next For Novavax?\nBullish traders are looking to see the stock continue to trade within the pennant pattern for a while before breaking above the pattern resistance. A break above pattern resistance with a period of consolidation would hint that the stock may be ready to continue on a bullish run higher.\nBearish traders are looking to see the stock fade back below the pattern support once again. If the stock can hold below the pattern support, it may be ready to see a strong bearish push in the future.","kind":null,"is_publish_news":true,"is_publish_highlight":true,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[{"id":602058061,"gmtCreate":1638946138109,"gmtModify":1638946138490,"author":{"id":"3579777216498074","authorId":"3579777216498074","name":"JANICELSJ","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":4,"crmLevelSwitch":0,"authorIdStr":"3579777216498074","idStr":"3579777216498074"},"htmlText":"Like please&nbsp;","listText":"Like please&nbsp;","text":"Like please","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/602058061","repostId":1104758360,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"},{"id":602063114,"gmtCreate":1638941779586,"gmtModify":1638941779780,"author":{"id":"3581586064432892","authorId":"3581586064432892","name":"Skygeemusic","avatar":"https://static.tigerbbs.com/3f99d0ab8a8308e7405bd556cee37483","vip":1,"crmLevel":3,"crmLevelSwitch":0,"authorIdStr":"3581586064432892","idStr":"3581586064432892"},"htmlText":"👍","listText":"👍","text":"👍","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/602063114","repostId":1104758360,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":6896325,"gmtCreate":1638946142948,"gmtModify":1638946142980,"authorId":3579777216498074,"author":{"id":3579777216498074,"idStr":"3579777216498074","authorId":3579777216498074,"name":"JANICELSJ","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":4,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":602063114,"type":1,"supId":0,"prevId":0,"content":"Ok","text":"Ok","html":"Ok"},{"id":6896051,"gmtCreate":1638943259944,"gmtModify":1638943259978,"authorId":3581684923109887,"author":{"id":3581684923109887,"idStr":"3581684923109887","authorId":3581684923109887,"name":"732bc2e8","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":602063114,"type":1,"supId":0,"prevId":0,"content":"[smile]","text":"[smile]","html":"[smile]"}],"langContent":"CN"},{"id":602083268,"gmtCreate":1638940137215,"gmtModify":1638940137512,"author":{"id":"3579242284896142","authorId":"3579242284896142","name":"CherryPang","avatar":"https://static.tigerbbs.com/72256d5f02e9431fb7df955e5b3418f8","vip":1,"crmLevel":6,"crmLevelSwitch":0,"authorIdStr":"3579242284896142","idStr":"3579242284896142"},"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/602083268","repostId":1104758360,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":6895725,"gmtCreate":1638940505012,"gmtModify":1638940505115,"authorId":3569531614182731,"author":{"id":3569531614182731,"idStr":"3569531614182731","authorId":3569531614182731,"name":"Gabrielle_20","avatar":"https://static.tigerbbs.com/3687c03e4fcd937f9b3fa40fa7705b14","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":602083268,"type":1,"supId":0,"prevId":0,"content":"👌","text":"👌","html":"👌"}],"langContent":"CN"},{"id":602017004,"gmtCreate":1638939535994,"gmtModify":1638939536356,"author":{"id":"3586939439858903","authorId":"3586939439858903","name":"ASMH","avatar":"https://static.tigerbbs.com/c8c22c3127769d9bb7b4e8d291d98433","vip":1,"crmLevel":2,"crmLevelSwitch":0,"authorIdStr":"3586939439858903","idStr":"3586939439858903"},"htmlText":"Like&nbsp;","listText":"Like&nbsp;","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/602017004","repostId":1104758360,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"},{"id":602018603,"gmtCreate":1638939030763,"gmtModify":1638939030859,"author":{"id":"4094458351180860","authorId":"4094458351180860","name":"tarotsgirl","avatar":"https://static.tigerbbs.com/420d06ca5a618d9b6678a1fd09eb6383","vip":1,"crmLevel":3,"crmLevelSwitch":0,"authorIdStr":"4094458351180860","idStr":"4094458351180860"},"htmlText":"Any idea which countries using this vaccine?&nbsp;","listText":"Any idea which countries using this vaccine?&nbsp;","text":"Any idea which countries using this vaccine?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/602018603","repostId":1104758360,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"},{"id":602031667,"gmtCreate":1638937511722,"gmtModify":1638937511850,"author":{"id":"3586596744781365","authorId":"3586596744781365","name":"AliPharma","avatar":"https://static.tigerbbs.com/4ae50feeb2edce44d991e8e753fb37e5","vip":1,"crmLevel":5,"crmLevelSwitch":0,"authorIdStr":"3586596744781365","idStr":"3586596744781365"},"htmlText":"ok","listText":"ok","text":"ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/602031667","repostId":1104758360,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"}],"isCommentEnd":false,"newsSizeData":{"likeSize":97,"commentSize":8,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1104758360"}